ArticleBMC health services research2021

Cost utility analysis of Remdesivir and Dexamethasone treatment for hospitalised COVID-19 patients - a hypothetical study.

Andrea Carta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.